{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:56:32Z","timestamp":1790614592335,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jvs.2018.05.223","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T18:58:29Z","timestamp":1533927509000},"page":"137S-151S.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S","title":["Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients"],"prefix":"10.1016","volume":"68","author":[{"given":"Tatiana","family":"Chadid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Surowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke P.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.05.223_bib1","series-title":"National diabetes statistics report: estimates of diabetes and its burden in the United States","year":"2014"},{"key":"10.1016\/j.jvs.2018.05.223_bib2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.05.223_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejvs.2014.06.041","article-title":"Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes","volume":"48","author":"Elgzyri","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0312-328","article-title":"Limb-saving medicines sought to prevent amputations","volume":"18","author":"Willyard","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jvs.2018.05.223_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jvs.2006.12.022","article-title":"Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome","volume":"45","author":"Dick","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.05.223_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.05.223_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2018.05.223_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.05.223_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise Review: Cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.jvs.2018.05.223_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jvs.2015.02.061","article-title":"Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia","volume":"65","author":"Brewster","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib13","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2014.161","article-title":"Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls","volume":"22","author":"Gremmels","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2018.05.223_bib14","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2018.05.223_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","article-title":"Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia","volume":"56","author":"Powell","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1253\/circj.CJ-11-1135","article-title":"Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study","volume":"76","author":"Lee","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2018.05.223_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5966\/sctm.2014-0291","article-title":"Body management: mesenchymal stem cells control the internal regenerator","volume":"4","author":"Caplan","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jvs.2018.05.223_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A\u00a0perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jvs.2018.05.223_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.stem.2016.12.006","article-title":"Pericytes of multiple organs do not behave as mesenchymal stem cells in\u00a0vivo","volume":"20","author":"Guimaraes-Camboa","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jvs.2018.05.223_bib20","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1016\/j.biomaterials.2013.06.050","article-title":"The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy","volume":"34","author":"Copland","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jvs.2018.05.223_bib21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/jcp.22548","article-title":"Role of the EGFR ligand\/receptor system in the secretion of angiogenic factors in mesenchymal stem cells","volume":"226","author":"De Luca","year":"2011","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2018.05.223_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2018.05.223_bib23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jcyt.2013.05.020","article-title":"Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in\u00a0vitro","volume":"15","author":"Griffiths","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2018.05.223_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jcp.22239","article-title":"FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix","volume":"225","author":"Brewster","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2018.05.223_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biomaterials.2007.09.034","article-title":"Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen","volume":"29","author":"Brewster","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jvs.2018.05.223_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of mesenchymal stem cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jvs.2018.05.223_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.surg.2017.11.018","article-title":"Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures","volume":"163","author":"Morris","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.jvs.2018.05.223_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13287-015-0066-5","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy","volume":"6","author":"Li","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jvs.2018.05.223_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"Meirelles Lda","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jvs.2018.05.223_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","article-title":"Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms","volume":"109","author":"Kinnaird","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.05.223_bib31","doi-asserted-by":"crossref","first-page":"015005","DOI":"10.1088\/1758-5082\/6\/1\/015005","article-title":"In\u00a0vitro and in\u00a0vivo angiogenic capacity of BM-MSCs\/HUVECs and AT-MSCs\/HUVECs cocultures","volume":"6","author":"Ma","year":"2014","journal-title":"Biofabrication"},{"key":"10.1016\/j.jvs.2018.05.223_bib32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bmt.2011.196","article-title":"Angiogenic potential of BM MSCs derived from patients with critical leg ischemia","volume":"47","author":"Smadja","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jvs.2018.05.223_bib33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/jcmm.13071","article-title":"Human adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury","volume":"21","author":"Collett","year":"2017","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jvs.2018.05.223_bib34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.115.304026","article-title":"Adipose stromal cells differentiate along a smooth muscle lineage pathway upon endothelial cell contact via induction of activin A","volume":"115","author":"Merfeld-Clauss","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.05.223_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/096368916X692212","article-title":"Human adipose-derived stem cells suppress elastase-induced murine abdominal aortic inflammation and aneurysm expansion through paracrine factors","volume":"26","author":"Xie","year":"2017","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jvs.2018.05.223_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jvs.2016.09.034","article-title":"Evaluation of the stromal vascular fraction of adipose tissue as the basis for a stem cell-based tissue-engineered vascular graft","volume":"66","author":"Krawiec","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib37","first-page":"454","article-title":"Adipose stem cell function maintained with age: an intra-subject study of long-term cryopreserved cells","volume":"37","author":"Kokai","year":"2017","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.jvs.2018.05.223_bib38","doi-asserted-by":"crossref","first-page":"e000241","DOI":"10.1161\/JAHA.113.000241","article-title":"Hypercholesterolemia induces oxidant stress that accelerates the ageing of hematopoietic stem cells","volume":"3","author":"Tie","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2018.05.223_bib39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","article-title":"Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis","volume":"135","author":"Hu","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2018.05.223_bib40","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","article-title":"Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells","volume":"26","author":"Rosova","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jvs.2018.05.223_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s007740170061","article-title":"Stromal cell activity in bone marrow from the tibia and iliac crest of patients with rheumatoid arthritis","volume":"19","author":"Suzuki","year":"2001","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"Suppl 4","key":"10.1016\/j.jvs.2018.05.223_bib42","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0020-1383(14)70009-9","article-title":"Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest?","volume":"45","author":"Narbona-Carceles","year":"2014","journal-title":"Injury"},{"key":"10.1016\/j.jvs.2018.05.223_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17305\/bjbms.2013.2409","article-title":"Rat bone marrow stem cells isolation and culture as a bone formative experimental system","volume":"13","author":"Smajilagic","year":"2013","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.jvs.2018.05.223_bib44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13287-015-0146-6","article-title":"Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture","volume":"6","author":"Pogozhykh","year":"2015","journal-title":"Stem Cell Res Ther"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418316355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418316355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:23:10Z","timestamp":1760041390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521418316355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0741521418316355"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.05.223","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.05.223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}